Immunology: Current Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Opinion   
  • Immunol Curr Res 2024,

Advancements in Immunotherapy: Harnessing the Power of the Immune System

Mia Ava*
Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia
*Corresponding Author : Mia Ava, Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia, Email: avam98@gmail.com

Received Date: Mar 01, 2024 / Published Date: Mar 31, 2024

Abstract

Immunotherapy has emerged as a promising approach in the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases. By leveraging the body's own immune system to combat these conditions, immunotherapy offers potential advantages over traditional treatments such as chemotherapy and radiation therapy. This article provides an overview of recent advancements in immunotherapy, including monoclonal antibodies, checkpoint inhibitors, adoptive cell therapy, and cancer vaccines. Additionally, challenges and future directions in the field are discussed, highlighting the need for continued research and innovation to fully realize the potential of immunotherapy.

Citation: Ava M (2024) Advancements in Immunotherapy: Harnessing the Powerof the Immune System. Immunol Curr Res, 8: 186.

Copyright: © 2024 Ava M. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top